AUSTRALIA-WIDE LOW FLAT RATE $9.90

Close Notification

Your cart does not contain any items

Biofilm-based Healthcare-associated Infections

Volume II

Gianfranco Donelli

$260.95   $208.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer International Publishing AG
27 November 2014
The aim of this book is to provide readers with a wide overview of the main healthcare-associated infections caused by bacteria and fungi able to grow as biofilm. The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities. Clinicians, hygienists and microbiologists will be updated by leading scientists on the state-of-art of biofilm-based infections and on the most innovative strategies for prevention and treatment of these infections, often caused by emerging multidrug-resistant biofilm-growing microorganisms.
Edited by:  
Imprint:   Springer International Publishing AG
Country of Publication:   Switzerland
Edition:   2015 ed.
Volume:   831
Dimensions:   Height: 254mm,  Width: 178mm,  Spine: 13mm
Weight:   5.343kg
ISBN:   9783319097817
ISBN 10:   3319097814
Series:   Advances in Experimental Medicine and Biology
Pages:   195
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Persister cells in biofilm associated infections.- Fungal biofilms in human disease.- Biofilm-Infected Pressure Ulcers: Current Knowledge and Emerging Treatment Strategies.- Microbial biofilms and adverse reactions to gel fillers used in cosmetic surgery.- Role of biofilms in breast implant associated infections and capsular contracture.- Innovative strategies for combating biofilm-based infections.- Antimicrobial polymers for anti-biofilm medical devices: state of art and perspectives.- Antimicrobial Photodynamic Therapy for Treatment of Biofilm-based Infections.- Anti-Biofilm Agents in Control of Device-Related Infections.- Lipid- and polymer-based drug delivery carriers for eradicating microbial biofilms causing medical device-related infections.

See Also